These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 16047643

  • 1. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy.
    Yang Y, Ohta K, Shimizu M, Nakai A, Kasahara Y, Yachie A, Koizumi S.
    Clin Nephrol; 2005 Jul; 64(1):35-40. PubMed ID: 16047643
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children.
    Vaz de Castro PAS, Bitencourt L, Pereira BWS, Lima AQR, Hermida HS, Moreira Neto CR, Mestriner MD, Simões E Silva AC.
    Pediatr Nephrol; 2022 Mar; 37(3):499-508. PubMed ID: 34686915
    [Abstract] [Full Text] [Related]

  • 3. Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade.
    Ferrari P, Marti HP, Pfister M, Frey FJ.
    J Hypertens; 2002 Jan; 20(1):125-30. PubMed ID: 11791035
    [Abstract] [Full Text] [Related]

  • 4. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H, Muryan A, Young P, Forrester M, Iotti A, Pereyra H, Lombi F, Seminario O, Alonso M, Iotti R.
    Medicina (B Aires); 2007 Jan; 67(5):445-50. PubMed ID: 18051227
    [Abstract] [Full Text] [Related]

  • 5. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
    Esnault VL, Ekhlas A, Nguyen JM, Moranne O.
    Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
    [Abstract] [Full Text] [Related]

  • 6. Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome.
    Zhang Y, Wang F, Ding J, Zhang H, Liu X, Wang S, Xiao H, Yao Y, Liu J, Zhong X, Guan N, Su B, Wu G, Yu L.
    Pediatr Nephrol; 2016 Jan; 31(1):67-72. PubMed ID: 26248473
    [Abstract] [Full Text] [Related]

  • 7. Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy.
    Horita Y, Tadokoro M, Taura K, Suyama N, Taguchi T, Miyazaki M, Kohno S.
    Hypertens Res; 2004 Dec; 27(12):963-70. PubMed ID: 15894837
    [Abstract] [Full Text] [Related]

  • 8. Combination therapy with lamivudine and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker for hepatitis B virus-associated glomerulonephritis with mild to moderate proteinuria: a clinical review of 38 cases.
    Sun LJ, Shan JP, Cui RL, Yuan WJ, Jiang GR.
    Int Urol Nephrol; 2017 Jun; 49(6):1049-1056. PubMed ID: 28283858
    [Abstract] [Full Text] [Related]

  • 9. [Additive antiproteinuric effect of angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis].
    Iimura O, Kusano E, Tanba K, Yanagiba S, Amemiya M, Ando Y, Honma S, Muto S, Asano Y.
    Nihon Jinzo Gakkai Shi; 2003 Jul; 45(5):439-44. PubMed ID: 14509219
    [Abstract] [Full Text] [Related]

  • 10. Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy.
    Horita Y, Taura K, Taguchi T, Furusu A, Kohno S.
    Nephrology (Carlton); 2006 Oct; 11(5):462-6. PubMed ID: 17014562
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of angiotensin-converting enzyme inhibitors/angiotensin receptor blocker therapy for IgA nephropathy: A meta-analysis of randomized controlled trials.
    Ji Y, Yang K, Xiao B, Lin J, Zhao Q, Bhuva MS, Yang H.
    J Cell Biochem; 2019 Mar; 120(3):3689-3695. PubMed ID: 30270542
    [Abstract] [Full Text] [Related]

  • 12. Beneficial effects of high-dose losartan in IgA nephritis.
    Woo KT, Chan CM, Tan HK, Choong HL, Foo M, Vathsala A, Lee EJ, Tan CC, Lee GS, Tan SH, Lim CH, Chiang GS, Fook-Chong S, Wong SK.
    Clin Nephrol; 2009 Jun; 71(6):617-24. PubMed ID: 19473629
    [Abstract] [Full Text] [Related]

  • 13. [Multicenter investigation of therapeutic status of children with IgA nephropathy in China].
    Working Group for National Survey on Status of Diagnosis and Treatment of Childhood Renal Diseases.
    Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):486-90. PubMed ID: 24267127
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy an ACE inhibitor and an angiotensin receptor blocker for IgA nephropathy: a meta-analysis.
    Cheng J, Zhang X, Tian J, Li Q, Chen J.
    Int J Clin Pract; 2012 Oct; 66(10):917-23. PubMed ID: 22994326
    [Abstract] [Full Text] [Related]

  • 15. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.
    Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
    [Abstract] [Full Text] [Related]

  • 16. Reply to Yang et al. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin receptor blocker (ARB) in pediatric patients with IgA nephropathy.
    Mandal A.
    Clin Nephrol; 2006 Mar; 65(3):227; author reply 227-8. PubMed ID: 16550756
    [No Abstract] [Full Text] [Related]

  • 17. Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy.
    Nakamura T, Inoue T, Sugaya T, Kawagoe Y, Suzuki T, Ueda Y, Koide H, Node K.
    Am J Hypertens; 2007 Nov; 20(11):1195-201. PubMed ID: 17954367
    [Abstract] [Full Text] [Related]

  • 18. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
    Kim HJ, Ryu JH, Han SW, Park IK, Paik SS, Park MH, Paik DJ, Chung HS, Kim SW, Lee JU.
    Nephron Physiol; 2004 Nov; 97(4):p58-65. PubMed ID: 15331931
    [Abstract] [Full Text] [Related]

  • 19. Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.
    Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Sekizuka K, Ebihara I, Koide H.
    Am J Nephrol; 2000 Nov; 20(5):373-9. PubMed ID: 11092994
    [Abstract] [Full Text] [Related]

  • 20. Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies.
    Campbell R, Sangalli F, Perticucci E, Aros C, Viscarra C, Perna A, Remuzzi A, Bertocchi F, Fagiani L, Remuzzi G, Ruggenenti P.
    Kidney Int; 2003 Mar; 63(3):1094-103. PubMed ID: 12631093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.